Orthobiologics Market By Product Type (Viscosupplementation Products, Demineralized Bone Matrices, Synthetic Orthobiologics, Bone Morphogenic Protein, Allografts, Plasma-Rich Protein, Bone Marrow Aspirate Concentrate), By Application (Osteoarthritis And Degenerative Arthritis, Spinal Fusion, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial And Dental Applications) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Industry Outlook

The global orthobiologics market is expected to reach US$ 8,136.9 million in 2026, with a compound annual growth rate (CAGR) of 5.7% from 2018 to 2026. Orthobiologics refer to biologics and cellular therapies in orthopaedics made of a range of products such as recombinant growth factors, bone void fillers, stem cells, and grafts. Orthobiologics has evolved in the last two decades, resulting in a significant role in modern orthopaedic surgeries and therapies. Extensive knowledge of stem cells and biological growth factors in the healing of musculoskeletal injuries, bone regeneration, and tendon and ligament repair has fueled the use of orthobiologics in a variety of orthopaedic ailments. The various products in orthobiologics include platelet-rich plasma (PRP), stem cells, bone grafts, autologous conditioned serum, and growth factors.

Orthobiologics are becoming more popular in sports medicine due to their low side effects and quick recovery time.PRP has demonstrated promising results in the treatment of tendinopathies in adults and is being used as an aid in other sports injury treatments. Other orthopaedic applications of orthobiologics in sports medicine include ACL rupture treatment and cartilage damage, among others. According to the Centers for Disease Control and Prevention (CDC), more than 3.5 million children below the age of 14 receive medical treatment for sports injuries each year in the U.S. alone. Thus, growing sports injuries are a major driver of the growth of the orthobiologics market. As orthobiologic treatments are in their nascent stage, the treatment cost is higher as compared to traditional invasive therapies. Moreover, lower insurance coverage for orthobiologists would further hinder market growth in developing nations.

Market Synopsis

Osteoarthritis Prevalence to Drive the Orthobiologics Market

In 2017, osteoarthritis and degenerative arthritis held the largest share in the global orthobiologics market, owing to the rise in the target population suffering from degenerative arthritis, growing public awareness regarding the side effects of continuous oral medications, and the introduction of products with better clinical outcomes in osteoarthritis management. The spinal fusion segment is projected to exhibit the fastest growth rate during the forecast period owing to an increase in the number of spinal fusion surgeries globally. The American Academy of Orthopedic Surgeons (AAOS) suggests that a total of 0.46 million spinal fusion surgeries were performed in the U.S. in 2011. The advent of minimally invasive surgeries has further boosted the successful outcomes of spinal surgeries. The demand for bone grafts and stem cells has soared due to the growing number of orthopaedic procedures, consequently driving the orthobiologics market.

North America was the market leader in the global orthobiologics market.

In 2017, North America held the largest share in the global orthobiologics market due to factors such as developed healthcare facilities, patient awareness towards biologics and minimally invasive surgeries, affordability of expensive therapies, and growing research and development of orthobiologics for various orthopaedic disorders. Moreover, the growing prevalence of obesity and the high population of baby boomers susceptible to orthopaedic degenerative ailments further boost the orthobiologics market. As per the CDC Report 2015, osteoarthritis affects approximately 30 million adults in the U.S. Asia Pacific is projected to grow at the fastest rate owing to the budding biopharmaceutical and medical device companies, government initiatives to develop the healthcare infrastructure, and a flourishing medical tourism industry in countries such as India, Thailand, and Indonesia. A large patient pool and growing geriatric population in Japan and China further boost the demand for orthobiologics.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments was calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The orthopaedics market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on product type, application, and geography.

The market is studied in order to understand the current and future market trends in the orthobiologics market. The market is estimated by providing the compounded annual growth rate (CAGR) and a data forecast from 2018 to 2026. Strategic mergers, acquisitions, and collaboration among the key players for developing an innovative product pipeline are mentioned in the business strategy section. The key players currently engaged in the orthobiologics market are DePuy Synthes, Stryker Corporation, Medtronic plc, NuVasive Inc., Zimmer Biomet, Globus Medical, Inc., Orthofix International NV, Harvest Technologies Corporation, Seaspine Holdings Corporation, and RTI Surgicals, among others.

Key questions are answered in this report.

  • How will the global orthobiologics market perform during the forecast period from 2018 to 2026?
  • What are the latest trends in the orthobiologics market and valuable opportunities for key players?
  • Who are the leading players in the global orthobiologics market?
  • Which region leads and grows the most in the global orthobiologics market?
  • Currently, what are the reimbursement scenarios and regulatory structures for orthobiologists?
  • What are the drivers and restraints governing the global orthobiologics market?

Frequently Asked Questions:

The market for Orthobiologics Market is expected to reach US$ 8,136.9 Mn in 2026.

The Orthobiologics Market is expected to see significant CAGR growth over the coming years, at 5.7%.

The report is forecasted from 2018-2026.

The base year of this report is 2017.

DePuy Synthes, Stryker Corporation, Medtronic plc, NuVasive Inc., Zimmer Biomet, Globus Medical, Inc., Orthofix International NV, Harvest Technologies Corporation, Seaspine Holdings Corporation, and RTI Surgicals are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Aug 2018
Category:  Medical Devices
Report ID:   59292
Report Format:   PDF
Pages:   120
Rating:    4.1 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support